BMRN vs EDUC · P/E 40, rev $2.85B vs P/E 5.4, rev $22.9M
Biomarin Pharmaceutical Inc (BMRN) versus Educational Development Corporation (EDUC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Educational Development Corporation (EDUC) is a publishing company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EDUC revenue for 2026-02-28 was $22.9M. Net income was $2.3M. Revenue was up 245.3% from 2025-02-28 to 2026-02-28. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
Not investment advice. Open the BMRN and EDUC stock pages for the full models.
Not investment advice.